World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

O’Shaughnessy Ventures Backs Bioengineer Developing Injectable Blood Vessels

Cision PR Newswire by Cision PR Newswire
July 7, 2026
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Liam Aranda-Michel awarded an O’Shaughnessy Fellowship to engineer a therapy that restores circulation without major surgery

GREENWICH, Conn., July 7, 2026 /PRNewswire/ — O’Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has awarded an O’Shaughnessy Fellowship to Liam Aranda-Michel, a bioengineering researcher based in Cambridge, Massachusetts.

Aranda-Michel will use the fellowship to develop an injectable therapy that helps damaged tissue restore its own blood supply. When tissue loses circulation, current options are limited to drugs that signal the body to grow new vessels, often with mixed results, or invasive surgery. His approach delivers tiny, pre-formed vascular units directly into the tissue, supplying ready-made vessels rather than relying on the body to form them. He aims to offer a simpler, more accessible option for the millions of patients affected by conditions that cut off blood flow.

Aranda-Michel is an undergraduate studying biological engineering at MIT and conducts research at the Broad Institute of MIT and Harvard on injectable therapies for chronic disease. He has worked at tissue-engineering labs at several universities, including the University of Pittsburgh, where he co-developed an open-source platform for vascular research that runs at a fraction of the cost of commercial systems. His work has been published in the Cell Press journal Device. He also led a competitive robotics team for several years, qualifying for five world championships.

OSV’s founder and CEO, Jim O’Shaughnessy, commented, “Liam combines serious engineering talent with a genuine drive to help patients, and he’s taking on a problem that affects millions. We’re honored to be backing him.”

“Every real discovery starts at the edge of what we already understand, where our map runs out,” said Aranda-Michel. “The O’Shaughnessy Fellowship backs the people willing to step past that edge in the pursuit of better science for a better world. It’s a privilege to be one of them.”

About the O’Shaughnessy Fellowships Program

Launched in 2023, the O’Shaughnessy Fellowships program discovers and empowers the world’s boldest creatives, builders and researchers. Fellows receive a grant of up to $100,000 and gain access to OSV’s network of founders, investors and experts. OSV will award up to 20 fellowships in 2026.

Aranda-Michel is the eleventh fellow announced in 2026. More information about previous fellows is available at OSV’s website.

Applications for the O’Shaughnessy Fellowships are now closed and will reopen on Jan. 1, 2027. Individuals interested in applying can do so via OSV’s website.

About O’Shaughnessy Ventures

OSV is a creative investment firm that empowers creators to bring their ideas to life. Founded by Jim O’Shaughnessy, a pioneer in quantitative investing, founder of O’Shaughnessy Asset Management, and author of five books, OSV aims to provide financial support and to partner in growing the next life-changing creative ideas.

OSV combines Jim’s deeply rooted interest in all things art, science, investing and technology with his long-held desire to establish scenarios designed to help promising creators and their inspiring ideas succeed, regardless of age, location, job history or level of education. For more information, visit OSV’s website.

Media Contact:
Ena Gong
O’Shaughnessy Ventures LLC
(917) 355-7420
418148@email4pr.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oshaughnessy-ventures-backs-bioengineer-developing-injectable-blood-vessels-302818427.html

SOURCE O’Shaughnessy Ventures

Cision PR Newswire

Cision PR Newswire

Related Posts

Veritran Acquires PrismaCampaigns Inc., Expanding U.S. Presence

November 16, 2026

Insurance Expert Mike Newell Helps Readers Match Life Insurance Coverage to Changing Life Stages

November 16, 2026

Cadiz Issues Q3 2026 Letter to Shareholders

November 16, 2026

Jack Henry Named One of America’s Best Companies in Forbes Ranking

November 16, 2026

KEYCORP INVESTS IN MMG REAL ESTATE ADVISORS TO BUILD AN INTEGRATED INVESTMENT SALES AND FINANCING PLATFORM

November 16, 2026

RBC Wealth Management named Best Private Bank in Canada and Best Private Bank for Impact and Sustainable Investing globally at the PWM Global Private Banking Awards, in association with The Banker

November 16, 2026

Popular News

  • Veritran Acquires PrismaCampaigns Inc., Expanding U.S. Presence

    0 shares
    Share 0 Tweet 0
  • Insurance Expert Mike Newell Helps Readers Match Life Insurance Coverage to Changing Life Stages

    0 shares
    Share 0 Tweet 0
  • Cadiz Issues Q3 2026 Letter to Shareholders

    0 shares
    Share 0 Tweet 0
  • RBC Wealth Management named Best Private Bank in Canada and Best Private Bank for Impact and Sustainable Investing globally at the PWM Global Private Banking Awards, in association with The Banker

    0 shares
    Share 0 Tweet 0
  • KEYCORP INVESTS IN MMG REAL ESTATE ADVISORS TO BUILD AN INTEGRATED INVESTMENT SALES AND FINANCING PLATFORM

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler